Health
AstraZeneca vaccine trial hold leaves US participants in limbo – STAT
Experts say there’s no need to worry about this group or their data, because such trials are designed to account for such situations.
For the 20-something-year-old Hispanic man, volunteering for AstraZenecas Phase 3 Covid-19 vaccine study was an easy decision. His father, after all, had been briefly hospitalized with Covid-19, and, even beyond that personal motivation, signing up was the right thing to do, he told STAT.
The clinical trial participant, who lives in the western U.S., got his first shot in early September he doesnt know if he got the actual vaccine or a saline placebo, in line with the studys double-blinded desi…
-
General16 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General18 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General19 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News18 hours agoSurgeon partner of former premier to testify over his patient’s death